Results 221 to 230 of about 175,633 (246)

Precision mRNA Delivery via Ultrasound‐Controlled Release Perfluorocarbon Emulsions: An Innovative Ultrasound Theranostic Strategy with 19F MRI Feasibility

Small, EarlyView.
A key challenge in advancing messenger RNA (mRNA) therapeutics in cardiovascular diseases lies in achieving controlled release at the precise site within the vasculature. This study presents the development of perfluorocarbon nanodroplets with exceptional theranostic potential, enabling real‐time tracking through ultrasound and fluorine‐19 (19F ...
Haikun Liu, Mark Louis P. Vidallon, Yuyang Song, Aidan P. G. Walsh, Henry Gordon, Shulei Ren, Pengkai Shi, Bangyan Xu, Mitchell J. Moon, Sylvain Trépout, Rico F. Tabor, Alexis I. Bishop, Ulrich Flögel, Karlheinz Peter, Xiaowei Wang   +14 more
wiley   +1 more source

Elucidating the role of KLRD1 in coronary atherosclerosis: harnessing bioinformatics and machine learning to advance understanding. [PDF]

J Cardiothorac Surg
Liang H, Liang X, Zheng M, Wang S.
europepmc   +1 more source

Integrated multi‐omics analysis reveals metabolic reprogramming as a key driver of angiotensin II‐induced vascular remodeling

VIEW, EarlyView.
This study investigates the molecular alterations underlying angiotensin II (Ang II)‐induced vascular remodeling in cardiovascular diseases using a multi‐omics approach. Through data exploration and integrated multi‐omics analysis, our findings reveal that Ang II‐driven vascular injury in vascular smooth muscle cells is mediated by metabolic ...
Yiwei Hu, Dan Zhao, Lingyan Zhong, Jianxujie Zheng, Dongxue Zhang, Enhui Wu, Qian Shi, Liang Qiao, Ling Lin   +8 more
wiley   +1 more source

Coronary Atherosclerosis and Subclinical Cerebral Small Vessel Disease: A Robust Association Beyond Intracranial Atherosclerosis and Cardiac Systolic Function. [PDF]

J Am Heart Assoc
Wang Z, Li S, Liu D, Cai X, Jing J, Wang Y, Wei T, Pan Y, Wang Y.   +8 more
europepmc   +1 more source

Advances in cholesterol and lipoproteins detection for healthcare: A review

VIEW, EarlyView.
Cholesterol is one of the main biomarkers related to the development of cardiovascular diseases. Its detection still relies on traditional methods of analysis, such as gas and liquid chromatographies. Detection of free cholesterol in saliva with redox or enzymatic sensors or detection of lipoproteins in blood with aptamer sensors are currently the most
Jacopo Giaretta, Somayeh Fardindoost, Azadeh Abdi, Kaveh Yazdani, Longfei Yin, Syamak Farajikhah, Mina Hoorfar, Fariba Dehghani   +7 more
wiley   +1 more source

Geographical mortality distribution of cardiovascular diseases: First report from South Khorasan, Iran

Caspian Journal of Internal Medicine, 2017
Toba Kazemi, Gholam-reza Sharifzadeh, Nahid Borna   +2 more
doaj  

HDL cholesterol as a mediator of the relationship between breastfeeding and coronary atherosclerosis from a two-step Mendelian randomization analysis. [PDF]

Sci Rep
Zhang B, Yang B, Xiu W, Xue D, Zheng Y, Wei J, Dai Y.   +6 more
europepmc   +1 more source

Imperative for a health‐centred focus on climate change in radiology

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Summary Climate change negatively impacts individual and population‐level health through multiple pathways, including poor air quality, extreme heat and changes in infectious disease. These health effects will lead to higher health system and medical imaging utilisation.
Omar Taboun, Chloe DesRoche, Kate Hanneman   +2 more
wiley   +1 more source

Topological Data Analysis in the Assessment of Coronary Atherosclerosis: A Comprehensive Narrative Review. [PDF]

Mayo Clin Proc Digit Health
Singh Y, Hathaway QA, Farrelly C, Budoff MJ, Erickson B, Collins JD, Blaha MJ, Leiner T, Lopez-Jimenez F, Rozenblit J, Sarkar D, Carlsson G.   +11 more
europepmc   +1 more source

Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial

Addiction, EarlyView.
Abstract Background and aims Evidence for motivational interviewing for smoking cessation is weak, with limited data on long‐term abstinence rates. This trial aimed to evaluate the effect of in‐hospital motivational interviewing‐based smoking cessation counselling combined with proactive referral to community‐based follow‐up on 6‐ and 12‐month ...
Karin Pleym, Elise Sverre, Harald Weedon‐Fekjær, Mohpal Singh Kahlon, Marie Stugaard, Einar Husebye, Serena Tonstad, Toril Dammen, John Munkhaugen   +8 more
wiley   +1 more source